EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 14,130
+310 (2.24%)
Sep 19, 2025, 3:30 PM KST
EuBiologics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | - | -13,879 | -1,099 | -27,574 | -60,134 |
Depreciation & Amortization | - | 9,168 | 7,882 | 6,564 | 5,949 |
Loss (Gain) From Sale of Assets | - | -1,666 | -193.28 | 0.88 | 5.24 |
Asset Writedown & Restructuring Costs | - | 21,906 | 845.09 | 708.04 | - |
Loss (Gain) From Sale of Investments | - | 200.32 | -2,142 | -253.29 | 180.59 |
Loss (Gain) on Equity Investments | - | 512.58 | 321.04 | 124.61 | 0.15 |
Stock-Based Compensation | - | 777.07 | 4,032 | 1,992 | 346.27 |
Provision & Write-off of Bad Debts | - | -6.28 | 44.04 | -106.53 | 260.57 |
Other Operating Activities | - | 2,192 | 3,531 | 19,866 | 52,844 |
Change in Accounts Receivable | - | -2,747 | -700.88 | -1,144 | -1,775 |
Change in Inventory | - | 3,754 | -6,679 | -5,153 | -1,643 |
Change in Accounts Payable | - | -220.46 | 548.03 | -405.95 | -96.77 |
Change in Other Net Operating Assets | - | 6,460 | 50.79 | -2,221 | 5,723 |
Operating Cash Flow | - | 26,452 | 6,440 | -7,602 | 1,659 |
Operating Cash Flow Growth | - | 310.73% | - | - | - |
Capital Expenditures | - | -6,936 | -9,066 | -6,595 | -8,030 |
Sale of Property, Plant & Equipment | - | 89 | - | 0.29 | 5 |
Cash Acquisitions | - | - | - | -729.7 | - |
Sale (Purchase) of Intangibles | - | -36,721 | -15,860 | -2,565 | -1,909 |
Investment in Securities | - | 9.39 | 22,844 | -28,296 | -4,499 |
Other Investing Activities | - | 15,128 | -136.27 | -31.84 | -76.91 |
Investing Cash Flow | - | -28,110 | -2,132 | -38,244 | -15,245 |
Short-Term Debt Issued | - | 2,663 | 6,000 | - | 5,402 |
Long-Term Debt Issued | - | - | - | - | 4,000 |
Total Debt Issued | - | 2,663 | 6,000 | - | 9,402 |
Short-Term Debt Repaid | - | -2,507 | - | -2,300 | -901.82 |
Long-Term Debt Repaid | - | -1,431 | -7,176 | -769.91 | -658.66 |
Total Debt Repaid | - | -3,938 | -7,176 | -3,070 | -1,560 |
Net Debt Issued (Repaid) | - | -1,274 | -1,176 | -3,070 | 7,841 |
Issuance of Common Stock | - | 61.86 | 1,093 | 1,326 | 53,062 |
Other Financing Activities | - | 1,779 | 717.31 | 1,031 | 104.41 |
Financing Cash Flow | - | 566.03 | 634.58 | -712.61 | 61,008 |
Foreign Exchange Rate Adjustments | - | -54.9 | -432.88 | 4.52 | -1.9 |
Net Cash Flow | - | -1,147 | 4,509 | -46,554 | 47,421 |
Free Cash Flow | - | 19,515 | -2,626 | -14,196 | -6,371 |
Free Cash Flow Margin | - | 28.13% | -4.74% | -36.05% | -22.36% |
Free Cash Flow Per Share | - | 535.43 | -72.15 | -400.46 | -227.38 |
Cash Interest Paid | - | 746.56 | 566.16 | 554.79 | 512.78 |
Cash Income Tax Paid | - | -37.16 | 3.25 | 43.52 | -3.41 |
Levered Free Cash Flow | - | -30,178 | -18,184 | -34,456 | - |
Unlevered Free Cash Flow | - | -29,873 | -18,024 | -34,088 | - |
Change in Working Capital | - | 7,247 | -6,781 | -8,924 | 2,208 |
Updated Mar 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.